Sumitomo Pharma Co., Ltd. (DNPUF)
OTCMKTS · Delayed Price · Currency is USD
4.000
0.00 (0.00%)
At close: Jan 21, 2025

Sumitomo Pharma Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Jan '25 Mar '24 Mar '23 Mar '22 Mar '21 Mar '20 2019 - 2015
Market Capitalization
1,4311,0452,4213,9526,9225,180
Upgrade
Market Cap Growth
15.99%-56.82%-38.75%-42.91%33.63%-47.21%
Upgrade
Enterprise Value
3,2863,5272,6044,9958,3766,785
Upgrade
Last Close Price
4.002.406.3810.2218.7513.10
Upgrade
PE Ratio
---8.5113.6213.68
Upgrade
PS Ratio
0.690.500.580.861.481.15
Upgrade
PB Ratio
2.071.010.790.711.180.88
Upgrade
P/TBV Ratio
---34.1537.03-
Upgrade
P/FCF Ratio
--92.7420.095.9114.51
Upgrade
P/OCF Ratio
--26.9615.365.6512.08
Upgrade
EV/Sales Ratio
1.501.700.621.081.801.51
Upgrade
EV/EBITDA Ratio
---6.1712.047.28
Upgrade
EV/EBIT Ratio
---10.1217.068.80
Upgrade
EV/FCF Ratio
-6.41-99.7525.397.1519.01
Upgrade
Debt / Equity Ratio
3.412.740.850.420.450.50
Upgrade
Debt / EBITDA Ratio
---2.893.783.14
Upgrade
Debt / FCF Ratio
--99.8211.912.248.21
Upgrade
Asset Turnover
0.350.310.450.430.400.46
Upgrade
Inventory Turnover
1.301.211.851.641.611.77
Upgrade
Quick Ratio
0.350.240.651.271.190.49
Upgrade
Current Ratio
0.640.521.031.791.650.73
Upgrade
Return on Equity (ROE)
-106.19%-111.89%-17.90%6.14%5.75%6.36%
Upgrade
Return on Assets (ROA)
-17.76%-21.74%-6.47%2.87%2.65%4.97%
Upgrade
Return on Capital (ROIC)
-26.63%-33.20%-9.23%3.95%3.60%7.01%
Upgrade
Earnings Yield
-136.28%-199.19%-23.15%11.75%7.34%7.31%
Upgrade
FCF Yield
-35.81%-159.79%1.08%4.98%16.92%6.89%
Upgrade
Dividend Yield
0.00%-2.48%2.26%1.35%1.99%
Upgrade
Payout Ratio
0.00%--19.72%19.78%32.16%
Upgrade
Buyback Yield / Dilution
0.00%0.00%0.00%0.00%0.00%0.00%
Upgrade
Total Shareholder Return
0.00%0.00%2.48%2.26%1.35%1.99%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.